Skip to main content
HLF
NYSE Trade & Services

Herbalife Reports Strong Q1 Earnings, Details Debt Refinancing, and Announces Strategic Acquisition

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
8
Price
$15.95
Mkt Cap
$1.7B
52W Low
$6.59
52W High
$20.4
Market data snapshot near publication time

summarizeSummary

Herbalife Ltd. reported robust Q1 2026 financial results with significant increases in net sales, net income, and operating cash flow, alongside the successful completion of a major debt refinancing at lower interest rates and a strategic acquisition.


check_boxKey Events

  • Strong Q1 Financial Performance

    Net sales increased 7.8% to $1.32 billion, net income rose 22.8% to $61.9 million, and diluted EPS reached $0.57, confirming and detailing the positive preliminary results announced in the concurrent 8-K.

  • Significant Operating Cash Flow Improvement

    Net cash provided by operating activities surged to $113.8 million for Q1 2026, a substantial increase from $0.2 million in the prior year, indicating improved operational efficiency.

  • Comprehensive Debt Refinancing Details

    The company provided full terms of the $800 million 7.750% senior secured notes due 2033 and the new $650 million 2026 Credit Facility, which refinanced existing higher-interest debt. This follows the preliminary announcement on May 1, 2026, and is expected to result in a $95 million charge in Q2 2026 for debt extinguishment.

  • Strategic Bioniq Acquisition Announced

    Herbalife acquired Bioniq's personalized nutrition business for $55 million in base consideration, with potential contingent payments up to $95 million based on sales milestones, expanding its product portfolio.


auto_awesomeAnalysis

Herbalife Ltd.'s Q1 2026 results demonstrate significant financial improvement, with notable growth in net sales, net income, and a substantial increase in operating cash flow. This positive performance is further bolstered by the detailed disclosure of a major debt refinancing, which, while previously announced, is now fully outlined, showing a reduction in interest rates that should benefit future profitability. The strategic acquisition of Bioniq's personalized nutrition business also signals a clear growth direction. While sales in China and North America declined, the overall financial health and strategic moves indicate a positive trajectory for the company, despite a one-time charge related to debt extinguishment expected in Q2.

At the time of this filing, HLF was trading at $15.95 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $6.59 to $20.40. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HLF - Latest Insights

HLF
May 06, 2026, 4:39 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
HLF
May 06, 2026, 4:28 PM EDT
Filing Type: 8-K
Importance Score:
8
HLF
May 06, 2026, 4:23 PM EDT
Filing Type: 10-Q
Importance Score:
8
HLF
May 01, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
9
HLF
May 01, 2026, 4:58 PM EDT
Filing Type: 8-K
Importance Score:
8
HLF
Apr 15, 2026, 7:32 PM EDT
Filing Type: 8-K
Importance Score:
9
HLF
Apr 14, 2026, 9:40 AM EDT
Filing Type: 8-K
Importance Score:
8
HLF
Apr 14, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
HLF
Mar 26, 2026, 8:28 AM EDT
Source: Zawya
Importance Score:
8
HLF
Mar 17, 2026, 4:31 PM EDT
Filing Type: DEF 14A
Importance Score:
8